NCI products
The end point of our supply provides the starting point for organisations working in research, health development and education
Compliance
Materials provided for non clinical use are appropriately-consented and the supply chain complies with all statutory and regulatory obligations including (but not limited to) the Human Tissue Act (2004) and associated Codes of Practice.
Quality
- Extensive regulatory expertise
- Laboratories regulated by HTA (Human Tissue Authority) and accredited by JACIE
- MHRA licence for collection, testing and processing of blood and IMP (Investigational Medicinal Products)
- Operational capacity from a national network of facilities governed by a single Quality Management System
COVID components
- Samples - microlitres of convalescent plasma – low, medium, high titre)
- Units of convalescent plasma - this is a restricted resource for public health facilities only
- Cones - peripheral blood mononuclear cell (PBMC) from convalescent plasma donors
Blood and blood components
- Donor samples - up to 5ml individual samples and deep-well microplates
- Cone - leukocyte reduction filter from a platelet apheresis donor
- Plasma
- Serum - off the clot and limited resource
- Cryoprecipitate
- Buffy coats
- Red cells
- Untested whole blood
Stem cells including unprocessed cord blood
- Fresh and frozen samples
- Placenta and cord tissue
- Fresh cord blood
- Cord blood additional processing / testing services
Therapeutic Apheresis Services (TAS)
- Waste patient cell exchange service
Red Cell Immunohaematology (RCI) and Reagents
- Surplus frozen patient samples, typically 0.5ml – 5ml
Cellular and Molecular Therapy (CMT)
- Haemopoietic progenitor cells - apheresis
Histocompatibility and Immunogenetics (H&I)
- Platelet immunology
- Granulocyte immunology
Tissue and Eye Services
- Tissue samples
- Bone products and samples
.